Alternative and complementary treatments for metabolic syndrome

Current Diabetes Reports

Volumn 11, Issue 3, 2011, Pages 173-178

  Power, Mariya ^a   Pratley, Richard ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Chromium; Cinnamon; Insulin resistance; Metabolic syndrome

Indexed keywords

ASCORBIC ACID; CHROMIUM; CHROMIUM PICOLINATE; CINNAMON EXTRACT; LINOLEIC ACID; LIPID; NICOTINIC ACID; PLACEBO; SULFONYLUREA;

ALTERNATIVE MEDICINE; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; BODY COMPOSITION; CARDIOVASCULAR RISK; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; INSULIN LIKE ACTIVITY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RECOMMENDED DRUG DOSE; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; CINNAMOMUM ZEYLANICUM; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; PICOLINIC ACIDS; PLANT EXTRACTS;

EID: 79955896139     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-011-0184-0     Document Type: Review

References (47)

1. Pratley RE. Metabolic syndrome: why the controversy? Curr Diab Rep. 2007;7:56-9.
2. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III) [no authors listed]. JAMA 2001, 285:2486-2497.
3. Jeejeebhoy KN, Chu RC, Marliss EB, et al. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr. 1977;30:531-8. (Pubitemid 8083749)
4. Via M, Scurlock C, Raikhelkar J, et al. Chromium infusion reverses extreme insulin resistance in a cardiothoracic ICU patient. Nutr Clin Pract. 2008;23:325-8.
5. Anderson RA. Chromium and parenteral nutrition. Nutrition. 1995;11:83-6.
6. Anderson RA. Nutritional factors influencing the glucose/insulin system: chromium. J Am Coll Nutr. 1997;16:404-10. (Pubitemid 27415500)
7. Anderson RA. Chromium, glucose intolerance and diabetes. J Am Coll Nutr. 1998;17:548-55. (Pubitemid 28546144)
8. National Research Counsil, Food and Nutrition Board. Recommended dietary allowances. 10th ed. Washington: National Academy Press; 1989.
9. Anderson RA, Polansky MM, Bryden NA, et al. Effects of chromium supplementation on urinary Cr excretion of human subjects and correlation of Cr excretion with selected clinical parameters. J Nutr. 1983;113:276-81. (Pubitemid 13111839)
10. Bunker VW, Lawson MS, Delves HT, Clayton BE. The uptake and excretion of chromium by the elderly. Am J Clin Nutr. 1984;39:797-802. (Pubitemid 14101238)
11. Anderson RA, Kozlovsky AS. Chromium intake, absorption and excretion of subjects consuming self-selected diets. Am J Clin Nutr. 1985;41:1177-83. (Pubitemid 15031359)
12. Offenbacher EG. Promotion of chromium absorptionby ascorbic acid. Trace Elem Electrolytes. 1994;11:178.
13. Lim TH, Sargent 3rd T. Kusubov N: Kinetics of trace element chromium(III) in the human body. Am J Physiol. 1983;244:R445-54.
14. Schwarz K, Mertz W. Chromium(III) and the glucose tolerance factor. Arch Biochem Biophys. 1959;85:292-5.
15. Vincent JB. Elucidating a biological role for chromium at a molecular level. Acc Chem Res. 2000;33:503-10.
16. Hummel M, Standl E, Schnell O. Chromium in metabolic and cardiovascular disease. Horm Metab Res. 2007;39:743-51. (Pubitemid 350099824)
17. Cefalu WT, Hu FB. Role of chromium in human health and in diabetes. Diab Care. 2004;27:2741-51. (Pubitemid 39441482)
18. Cefalu WT, Wang ZQ, Zhang XH, et al. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J Nutr. 2002;132:1107-14. (Pubitemid 34606436)
19. Sherman L, Glennon JA, Brech WJ, et al. Failure of trivalent chromium to improve hyperglycemia in diabetes mellitus. Metabolism. 1968;17:439-42.
20. Rabinowitz MB, Gonick HC, Levin SR, Davidson MB. Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Diab Care. 1983;6:319-27. (Pubitemid 13078710)
21. Lee NA, Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diab Care. 1994;17:1449-52. (Pubitemid 24369730)
22. Thomas VL, Gropper SS. Effect of chromium nicotinic acid supplementation on selected cardiovascular disease risk factors. Biol Trace Elem Res. 1996;55:297-305. (Pubitemid 27152812)
23. Trow LG, Lewis J, Greenwood RH, et al. Lack of effect of dietary chromium supplementation on glucose tolerance, plasma insulin and lipoprotein levels in patients with type 2 diabetes. Int J Vitam Nutr Res. 2000;70:14-8. (Pubitemid 30086465)
24. Gunton JE, Cheung NW, Hitchman R, et al. Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance. Diab Care. 2005;28:712-3. (Pubitemid 40315337)
25. Anderson RA, Cheng N, Bryden NA, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997;46:1786-91. (Pubitemid 27456412)
26. Cefalu WT, Bell-Farrow AD, Stegner J, Wang ZQ, King T, Morgan T, et al. Effect of chromium picolinate on insulin sensitivity in vivo. J Trace Elem Exp Med. 1999;12:71-83. (Pubitemid 29231776)
27. Iqbal N, Cardillo S, Volger S, et al.: Chromium Picolinate Does Not Improve Key Features of Metabolic Syndrome in Obese Nondiabetic Adults. Metab Syndr Relat Disord 2009.
28. Lukaski HC, Bolonchuk WW, Siders WA, Milne DB. Chromium supplementation and resistance training: effects on body composition, strength, and trace element status of men. Am J Clin Nutr. 1996;63:954-65. (Pubitemid 26172387)
29. Grant KE, Chandler RM, Castle AL, Ivy JL. Chromium and exercise training: effect on obese women. Med Sci Sports Exerc. 1997;29:992-8.
30. Martin J, Wang ZQ, Zhang XH, et al. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diab Care. 2006;29:1826-32. (Pubitemid 44156637)
31. Proctor SD, Kelly SE, Stanhope KL, et al. Synergistic effects of conjugated linoleic acid and chromium picolinate improve vascular function and renal pathophysiology in the insulin-resistant JCR:LA-cp rat. Diab Obes Metab. 2007;9:87-95. (Pubitemid 44921046)
32. Roeback Jr JR, Hla KM, Chambless LE, Fletcher RH. Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers. A randomized, controlled trial. Ann Intern Med. 1991;115:917-24.
33. Abraham AS, Brooks BA, Eylath U. The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metabolism. 1992;41:768-71.
34. Padmavathi IJ, Rao KR, Venu L, et al. Chronic maternal dietary chromium restriction modulates visceral adiposity: probable underlying mechanisms. Diabetes. 2010;59:98-104.
35. Dugoua JJ, Seely D, Perri D, et al. From type 2 diabetes to antioxidant activity: a systematic review of the safety and efficacy of common and cassia cinnamon bark. Can J Physiol Pharmacol. 2007;85:837-47. (Pubitemid 350189725)
36. Anderson RA, Broadhurst CL, Polansky MM, et al. Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem. 2004;52:65-70.
37. Imparl-Radosevich J, Deas S, Polansky MM, et al. Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling. Horm Res. 1998;50:177-82. (Pubitemid 28472847)
38. Qin B, Nagasaki M, Ren M, et al. Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diab Res Clin Pract. 2003;62:139-48. (Pubitemid 37414980)
39. Qin B, Nagasaki M, Ren M, et al. Cinnamon extract prevents the insulin resistance induced by a high-fructose diet. Horm Metab Res. 2004;36:119-25. (Pubitemid 38392254)
40. Sheng X, Zhang Y, Gong Z, et al. Improved insulin resistance and lipid metabolism by cinnamon extract through activation of peroxisome proliferator-activated receptors. PPAR Res. 2008;2008:581348.
41. Khan A, Safdar M, Ali Khan MM, et al. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diab Care. 2003;26:3215-8. (Pubitemid 37466877)
42. Vanschoonbeek K, Thomassen BJ, Senden JM, et al. Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients. J Nutr. 2006;136:977-80.
43. Crawford P: Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med 2009, 22:507-512. This is a recent clinical trial demonstrating positive effect of cinnamon extract on HbA1c levels in people with type 2 diabetes.
44. Ziegenfuss TN, Hofheins JE, Mendel RW, et al. Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr. 2006;3:45-53.
45. Feiner JJ, McNurlan MA, Ferris RE, et al. Chromium picolinate for insulin resistance in subjects with HIV disease: a pilot study. Diab Obes Metab. 2008;10:151-8.
46. Wang JG, Anderson RA, Graham 3rd GM, et al. The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study. Fertil Steril. 2007;88:240-3. (Pubitemid 47001380)
47. Solomon TP, Blannin AK. Effects of short-term cinnamon ingestion on in vivo glucose tolerance. Diab Obes Metab. 2007;9:895-901. (Pubitemid 47555211)